Hong Kong biotech company Prenetics is going public through a merger with Artisan Acquisition — a SPAC backed by Adrian Cheng, CEO of New World Development.
Hong Kong biotech company Prenetics is going public through a merger with Artisan Acquisition — a SPAC backed by Adrian Cheng, CEO of New World Development.